Physiological Associations and Prognostic Discrimination of an EIT-Derived Flow Index During Noninvasive Ventilation (NIV-EFI)
Physiological Associations and Prognostic Discrimination of an Electrical Impedance Tomography-Derived Flow Index During Noninvasive Ventilation: A Multicenter Prospective Cohort With a Nested Physiological Substudy
This is a multicenter prospective observational cohort study with a nested physiological substudy. It aims to enroll 220 adults with acute hypoxemic respiratory failure (AHRF) initiating mask noninvasive ventilation (NIV). The study will assess the measurement feasibility, physiological associations, and early prognostic discrimination of the electrical impedance tomography (EIT)-derived flow index (EFI) during NIV. The primary objective is to estimate how well pre-landmark T1 EFI discriminates the risk of endotracheal intubation or all-cause death through 48 hours. A nested physiological substudy (n=20) will evaluate the within-patient association between EFI and airway occlusion pressure across fixed pressure support (PS) levels (5, 10, and 15 cmH2O). Clinical management remains independent of study measurements.
Descripción general del estudio
Estado
Estado
Condiciones
Condiciones
Intervención / Tratamiento
Intervención / Tratamiento
Descripción detallada
This study will enroll adults with AHRF for whom the treating team has decided to initiate mask NIV. The main cohort (n=220) is observational. EIT data will be acquired at baseline (T0), 60-120 min (T1), 20-24 h (T2), and 42-48 h (T3). The primary predictor is the median EFI across valid breaths during T1 (before the 2-h landmark). The primary endpoint is the first occurrence of endotracheal intubation or all-cause death after 2 h and through 48 h among patients eligible at the 2-h landmark.
A nested, non-randomized physiological substudy (n=20) will be conducted after T1. After confirming safety and obtaining separate informed consent, patients will undergo a fixed sequence of brief pressure support steps (PS 5, 10, and 15 cmH2O) with EPAP and FiO2 held at clinical settings. Brief airway occlusions will be performed at each level to measure occlusion pressure (Pocc and P0.1). The substudy aims to estimate the within-patient association between EFI and |Pocc|. The study was approved by the Ethics Committee of Ruijin Hospital (Approval No. 2026846). Written informed consent is obtained from all participants (and separate consent for the substudy).
Tipo de estudio
Tipo de estudio
Inscripción (Estimado)
Inscripción
Contactos y Ubicaciones
Estudio Contacto
Estudio Contacto
- Nombre: Rui Zhang
- Número de teléfono: +86-18801119381
- Correo electrónico: ccmzhangrui@foxmail.com
Ubicaciones de estudio
-
-
Shanghai Municipality
-
Shanghai, Shanghai Municipality, Porcelana, 200025
- Department of Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
-
Contacto:
- Yun Feng
- Número de teléfono: +86-17321113771
- Correo electrónico: fy11697@rjh.com.cn
-
-
Criterios de participación
Criterio de elegibilidad
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Método de muestreo
Población de estudio
Adults (aged 18 years or older) with acute hypoxemic respiratory failure (AHRF) for whom the treating clinical team has decided to initiate mask noninvasive ventilation (NIV) in the intensive care unit. A subset of stable patients will participate in the nested physiological sub-study.
Descripción
Inclusion Criteria:
- Age 18 years or older.
- Clinical diagnosis of AHRF and a decision to initiate NIV through an oronasal or full-face mask (PaO2/FiO2 ≤ 300 mmHg or FiO2 ≥ 0.40 to maintain oxygenation target).
- Consent and enrollment completed before NIV begins or within 60 min of initiation.
- Written informed consent from the patient or authorized representative (separate consent for substudy).
Exclusion Criteria:
- Immediate clinical need for endotracheal intubation or clear contraindication to NIV.
- Facial trauma, severe chest-wall skin injury, or incisions preventing safe placement of EIT belt.
- Contraindication in EIT device manual (e.g., incompatible implanted device).
- Pregnancy or lactation.
- Baseline do-not-intubate (DNI) decision or comfort measures only.
- Inability to obtain valid consent.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Modelos observacionales: COHORT
- Perspectivas temporales: PROSPECTIVE
Número de grupos/cohortes
Cohortes e Intervenciones
Grupo / CohorteGrupo / Cohorte |
Intervención / TratamientoIntervención / Tratamiento |
|---|---|
|
Main Cohort
Adults with AHRF initiating mask NIV (n=220). Observational; T1 EFI is evaluated for discriminating 48-hour intubation or death. |
Standard clinical care through oronasal or full-face mask. Settings are directed by the treating team. Continuous EIT monitoring to derive the dimensionless flow index (EFI). |
|
Nested Physiological Substudy
A subset of the main cohort (n=20). Consenting patients undergo brief, sequential pressure support (PS) adjustments (5, 10, 15 cmH2O) and airway occlusions to measure EFI and |Pocc| associations. |
Standard clinical care through oronasal or full-face mask. Settings are directed by the treating team. Continuous EIT monitoring to derive the dimensionless flow index (EFI). Protocol-specified PS steps (5, 10, 15 cmH2O) and device-supported airway occlusions performed in the physiological substudy. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Incidence of Endotracheal Intubation or All-Cause Death (2h to 48h)
Periodo de tiempo: After 2 hours through 48 hours.
|
The first occurrence of endotracheal intubation or all-cause death after 2 hours and through 48 hours from NIV initiation, among patients alive and still receiving NIV at the 2-hour landmark.Unit of Measure: Proportion of participants (or Event count) |
After 2 hours through 48 hours.
|
Medidas de resultado secundarias
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Discrimination Performance (AUC) of T1 EFI
Periodo de tiempo: Within 72 hours
|
Area under the receiver operating characteristic curve (AUC) of the pre-landmark T1 EFI for predicting the primary composite endpoint.Unit of Measure: AUC (dimensionless, 0-1) |
Within 72 hours
|
|
Within-Patient Association between EFI and |Pocc|
Periodo de tiempo: Within 2 to 6 hours after NIV initiation.
|
The within-patient slope of the association between EFI and the absolute magnitude of occlusion pressure (|Pocc|) across fixed pressure support levels in the physiological sub-study. Unit of Measure: cmH2O per unit of EFI |
Within 2 to 6 hours after NIV initiation.
|
|
Intubation or Death by Day 7
Periodo de tiempo: Within day 7
|
ncidence of endotracheal intubation or all-cause mortality by day 7.Unit of Measure: Proportion of participants |
Within day 7
|
|
28-Day All-Cause Mortality
Periodo de tiempo: within day 28
|
All-cause mortality rate at day 28.Unit of Measure: Proportion of participants |
within day 28
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Colaboradores
Colaboradores
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Inicio del estudio
Finalización primaria (Estimado)
Finalización primaria
Finalización del estudio (Estimado)
Finalización del estudio
Fechas de registro del estudio
Enviado por primera vez
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Publicado por primera vez
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización publicada
Última actualización enviada que cumplió con los criterios de control de calidad
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
Otros números de identificación del estudio
- 2026846
- (2026) Lin Lun Shen No. 846 (Otro identificador: Ethics Committee of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine)
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
De-identified analysis datasets may be shared on reasonable request for verification, subject to ethics approval.
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .